共 50 条
Risk of pulmonary emboli after removal of an upper extremity central catheter associated with a deep vein thrombosis
被引:16
|作者:
Houghton, Damon E.
[1
,2
]
Billett, Henny Heisler
[3
,4
]
Gaddh, Manila
[5
]
Onadeko, Oluwatomiloba
[6
]
George, Gemlyn
[7
]
Wang, Tzu-Fei
[8
,9
]
Oo, Thein H.
[10
]
Feng, Mingen
[11
]
Dasgupta, Mahua
[11
]
Jaglal, Michael
[12
]
Streiff, Michael B.
[13
]
Simpson, Pippa
[11
]
Gali, Radhika
[14
]
Kreuziger, Lisa Baumann
[11
,15
]
机构:
[1] Mayo Clin, Dept Cardiovasc Dis, Div Vasc Med, 200 1st St, Rochester, MN 55905 USA
[2] Mayo Clin, Div Hematol Oncol, Dept Med, Rochester, MN 55905 USA
[3] Montefiore Med Ctr, Albert Einstein Coll Med, Div Hematol, Dept Oncol, Bronx, NY 10467 USA
[4] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Med, Div Hematol, Bronx, NY 10467 USA
[5] Emory Univ, Winship Canc Inst, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA
[6] Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA
[7] Univ Colorado, Dept Med, Div Hematol, Aurora, CO USA
[8] Univ Ottawa, Dept Med, Ottawa Hosp, Ottawa, ON, Canada
[9] Ottawa Hosp Res Inst, Ottawa, ON, Canada
[10] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[11] Med Coll Wisconsin, Dept Pediat, Div Quantitat Hlth Sci, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA
[12] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[13] Johns Hopkins Med Inst, Dept Med, Div Hematol, Baltimore, MD 21205 USA
[14] Montefiore Med Ctr, New York, NY USA
[15] Versiti, Milwaukee, WI USA
关键词:
CENTRAL VENOUS CATHETERS;
CANCER-PATIENTS;
THROMBOEMBOLISM;
ANTICOAGULATION;
MANAGEMENT;
GUIDANCE;
D O I:
10.1182/bloodadvances.2021004698
中图分类号:
R5 [内科学];
学科分类号:
1002 ;
100201 ;
摘要:
Standard treatment of catheter-associated upper extremity deep vein thrombosis (UE-DVT) is anticoagulation, although catheters are often removed for this indication. The optimal time for catheter removal and whether the act and/or timing of catheter removal is associated with pulmonary embolism (PE) remain unknown. A retrospective cohort study was performed at 8 participating institutions through the Venous thromboEmbolism Network US. Patients with hematologic malignancies and central venous catheter (CVC)-associated UE-DVT were included from 1 January 2010 through 31 December 2016. The primary outcome was objectively confirmed PE within 7 days of UE-DVT diagnosis in anticoagulated patients comparing early (<= 48 hours) vs delayed (>48 hours) catheter removal. A total of 626 patients were included, among whom 480 were treated with anticoagulation. Among anticoagulated patients, 255 underwent early CVC removal, while 225 had delayed or no CVC removal; 146 patients received no anticoagulation, among whom 116 underwent CVC removal alone. PE within 7 days occurred in 2 patients (0.78%) with early removal compared with 1 patient (0.44%) with delayed or no CVC removal (P > .9). PE or any cause of death within 7 days occurred in 3 patients in both the early removal (1.18%) and delayed/no removal (1.33%) groups (P > .9). In patients treated with CVC removal only (no anticoagulation), there were no PEs but 3 deaths within 7 days. In patients with hematological malignancy and CVC-associated UE-DVT, early removal of CVCs was not associated with an increased risk of PE compared with delayed or no removal.
引用
收藏
页码:2807 / 2812
页数:6
相关论文